Clinical trials follow a protocol approved by national health
authorities and ethics committees. All our clinical trial protocols
and outcomes (irrespective of the results), are made publicly
available, following the international reporting standard Equator (ie CONSORT).
Global standards for clinical trial activities are never compromised
and our research activities only take place in countries where the
environment, infrastructure, medical standards, Independent Ethics
Committees (IEC) or Institutional Review Boards (IRB) are all adequate
Doctors (investigators) must obtain free informed consent from each
participant and ensure their rights and well-being during and after
the trial. Investigators and research teams must be offered fair
reimbursement for their costs and labour. Trials must undergo
independent scientific and ethical review and approval, and are
subject to random audits by authorities during or after their execution.
For every clinical trial we sponsor, we establish safety committees
that report any adverse events on a global level to health
authorities, and who take appropriate action when required.
In addition, Bioethics Expert Groups keep track of emerging issues,
re-evaluate risks and act upon any findings. Current topics under
review include: global adherence to ethical guidelines, focus on
vulnerable populations in informed consent (especially children),
transparency in investigator-sponsored studies, use of social media
and collection of clinical data in real world evidence studies.